
| Administration | Basic Sciences | Clinical Sciences | Centers of Excellence |
|---|---|---|---|
|
|
|
Richard D. Wainford, PhD
Instructor of Pharmacology
LSUHSCSchool of Medicine – New Orleans MedicalEducationBuilding 1901 Perdido St Box P7-1 Room 5145 New Orleans, LA70112 Phone: (504) 568 4459 Email: rwainf@lsuhsc.edu
|
| Degrees |
BSc Zoology – 1999, University of Wales, Cardiff, Wales, UK PhD – Molecular Pharmacology/Toxicology 2004, University of Aberdeen, Department of Medicine and Therapeutics, Scotland, UK |
| Bio |
Undergraduate: University of Wales, Cardiff, Wales, UK (1996-1999) Post-Graduate: University of Aberdeen, Scotland, UK (1999-2004) Post-Doctoral: LSUHSC (2005-2008) Early Developing Investigator, COBRE grant (P20-RR018766) 2007-present |
| Research Interests |
My major research interest(s) lie in understanding the integrative physiological mechanisms underlying disease states and developing the appropriate pharmacological treatment. I have been working in this area since my doctoral studies during which time I investigated the mechanisms resulting in the development of cisplatin-induced nephrotoxicity under the guidance of Dr Hawksworth at the University of Aberdeen in the Department of Medicine and Therapeutics. I continued my training at the LSU Health Sciences Center under the guidance of Dr Kapusta investigating the endogenous role(s) of the opioid-like peptide nociceptin/Orphanin FQ (N/OFQ) in the regulation of systemic cardiovascular hemodynamics and renal excretory function. My current research focus is directed at understanding the central neural mechanisms involved in the regulation of blood pressure using an integrated translational approach employing in-vivo whole animal physiological studies and molecular biology techniques to examine protein expression and receptor function. In particular I am investigating the role(s) of central adrenoceptors and their downstream Gα-protein signaling pathways in salt-sensitive hypertension. |
| Selected Publications |
Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G(2007) In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Peptides. 28:1240-51
Wainford RD, Stewart K, Brown P, Weaver R, Hawksworth GM. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway. Toxicology. 249: 184-193.
Wainford RD, Kurtz K, Kapusta DR. Central G-alpha subunit protein mediated control of cardiovascular and renal excretory function in conscious Sprague-Dawley rats. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology. In press. |